Afuco™ Anti-Human CCR2 ADCC Therapeutic Antibody (MLN1202), ADCC Enhanced
Anti-CCR2 ADCC Enhanced Antibody (MLN1202) is an ADCC enhanced antibody produced by our Afuco™ platform. MLN1202 is a humanized monoclonal antibody with high specificity to CCR2, which interrupts MCP-1 binding to CCR2. MLN1202 is being developed for the treatment of immune mediated diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-095CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CCR2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |